ASX:OIL Optiscan Imaging (OIL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Optiscan Imaging Stock (ASX:OIL) 30 days 90 days 365 days Advanced Chart Get Optiscan Imaging alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume77,463 shsAverage VolumeN/AMarket CapitalizationA$129.48 millionP/E RatioN/ADividend Yield4.29%Price TargetN/AConsensus RatingN/A Company Overview Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia. Read More Receive OIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optiscan Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address OIL Stock News HeadlinesOptiscan begins breast cancer study in MelbourneJuly 1, 2025 | msn.comLong Shortz with Optiscan: New partnership targets real-time cancer detectionJune 26, 2025 | msn.comDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live. | American Alternative (Ad)Optiscan reveals imaging device InSpecta for veterinary marketJune 9, 2025 | msn.comOptiscan Imaging Expands into Veterinary Market with InSpecta™ DeviceJune 9, 2025 | tipranks.comOptiscan Imaging Advances Telepathology with New Cloud-Based SoftwareMay 26, 2025 | tipranks.comOptiscan and Mayo Clinic advance digital imaging tech for robotic breast cancer surgeryMay 13, 2025 | msn.comOptiscan Imaging Unveils InForm™ Device and Reports Strategic AdvancementsApril 29, 2025 | tipranks.comSee More Headlines OIL Stock Analysis - Frequently Asked Questions How were Optiscan Imaging's earnings last quarter? Optiscan Imaging Limited (ASX:OIL) issued its quarterly earnings data on Thursday, February, 28th. The company reported $0.00 earnings per share (EPS) for the quarter. Optiscan Imaging had a negative net margin of 230.34% and a negative trailing twelve-month return on equity of 40.05%. What other stocks do shareholders of Optiscan Imaging own? Based on aggregate information from My MarketBeat watchlists, some other companies that Optiscan Imaging investors own include Brookside Energy (BRK), (FIRE.V) (FIRE) and Core Lithium (CXO). Company Calendar Last Earnings2/28/2019Today8/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryBanking Current SymbolASX:OIL CIKN/A Webwww.optiscan.com Phone61 3 9538 3333FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$6.06 million Net Margins-230.34% Pretax MarginN/A Return on Equity-40.05% Return on Assets-40.54% Debt Debt-to-Equity Ratio1.59 Current Ratio8.59 Quick Ratio5.94 Sales & Book Value Annual SalesA$2.99 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow43.00 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares835,340,000Free FloatN/AMarket CapA$129.48 million OptionableNot Optionable Beta1.20 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:OIL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optiscan Imaging Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Optiscan Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OIL Stock Alerts